Anzeige
Meldung des Tages: Gold bei 5.250 USD – Dieser 37-Mio.-€-Goldentwickler sitzt auf einem möglichen $2-Milliarden-Projekt!!

Becton Dickinson News

Aktie
WKN:  857675 ISIN:  US0758871091 US-Symbol:  BDX Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
160,33 $
+0,70 $
+0,44%
140,20 € 19:40:58 Uhr
Depot/Watchlist
Marktkapitalisierung *
47,80 Mrd. €
Streubesitz
5,15%
KGV
31,83
Dividende
2,93 EUR
Dividendenrendite
2,23%
Nachhaltigkeits-Score
46 %
Index-Zuordnung
S&P 500
Weiter aufwärts? Long handeln - Jetzt mit Hebel 9,20: MM7TKK
Werbung

Becton Dickinson News

14.07.25 - PR Newswire
Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing
Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-​Volume Testing PR ...
14.07.25 - PR Newswire
Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing
Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-​Volume Testing PR ...
07.07.25 - PR Newswire
BD Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment
BD Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment PR Newswire
28.05.25 - PR Newswire
BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease
BD to Initiate Real-​World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease PR Newswire
27.05.25 - PR Newswire
BD to Present at Goldman Sachs 46th Annual Global Healthcare Conference
BD to Present at Goldman Sachs 46th Annual Global Healthcare Conference PR Newswire
21.05.25 - PR Newswire
Cancer Patients Face Elevated Risk of Carrying Antimicrobial Resistant 'Superbugs'
Cancer Patients Face Elevated Risk of Carrying Antimicrobial Resistant 'Superbugs' PR Newswire
13.05.25 - PR Newswire
BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies
BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies PR Newswire
12.05.25 - PR Newswire
BD to Announce Financial Results for its Third Quarter of Fiscal 2025
BD to Announce Financial Results for its Third Quarter of Fiscal 2025 PR Newswire
01.05.25 - PR Newswire
BD Reports Second Quarter Fiscal 2025 Financial Results
BD Reports Second Quarter Fiscal 2025 Financial Results PR Newswire
30.04.25 - PR Newswire
BD to Present at Bank of America Securities Health Care Conference
BD to Present at Bank of America Securities Health Care Conference PR Newswire
29.04.25 - PR Newswire
BD Board Declares Dividend
BD Board Declares Dividend PR Newswire
23.04.25 - PR Newswire
BD Launches Industry-First Bioabsorbable Mesh Designed for Umbilical Hernia Repair
BD Launches Industry-​First Bioabsorbable Mesh Designed for Umbilical Hernia Repair PR Newswire
21.04.25 - PR Newswire
BD Launches Next Generation Hemodynamic Monitoring Solution Providing Clinicians with AI-Driven Clinical Decision Support
BD Launches Next Generation Hemodynamic Monitoring Solution Providing Clinicians with AI-Driven Clinical Decision Support PR Newswire
03.04.25 - PR Newswire
BD to Announce Financial Results for its Second Quarter of Fiscal 2025
BD to Announce Financial Results for its Second Quarter of Fiscal 2025 PR Newswire
31.03.25 - PR Newswire
BD Named One of America's Most Innovative Companies by Fortune
BD Named One of America's Most Innovative Companies by Fortune PR Newswire
27.03.25 - PR Newswire
BD Names Gregory J. Hayes to Board of Directors
BD Names Gregory J. Hayes to Board of Directors PR Newswire
20.03.25 - PR Newswire
BD Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE™ Scaffold in Breast Implant Revision Surgery
BD Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE™ Scaffold in Breast Implant Revision Surgery PR Newswire
13.02.25 - PR Newswire
BD to Present at Investor Healthcare Conferences
BD to Present at Investor Healthcare Conferences PR Newswire
05.02.25 - PR Newswire
BD Reports First Quarter Fiscal 2025 Financial Results
BD Reports First Quarter Fiscal 2025 Financial Results PR Newswire
05.02.25 - PR Newswire
BD Announces Intent to Separate Biosciences and Diagnostic Solutions Business to Enhance Focus, Drive Growth and Unlock Value
BD Announces Intent to Separate Biosciences and Diagnostic Solutions Business to Enhance Focus, Drive Growth and Unlock Value PR Newswire

Newssuche

Videos

newspaper
19:20 Uhr -1,56%
Technical Trading: Kurzfristig Gold Long
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »